We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Neoleukin Therapeutics, Inc's financial performance into perspective.
September 9, 2021
Neoleukin Therapeutics Announces Appointment of Bill Arthur, Ph.D., as Vice President and Head of Research
September 7, 2021
August 5, 2021
September 13, 2021 at 7:00 AM EDT
August 11, 2021 at 8:00 AM EDT